Characteristic molecular signature of pericardial effusion identifies malignant cancer in pericardial disorder patients
ConclusionOur results suggest that etiology-specific molecular signatures can discriminate cancer patients within pericardial disorder patients. CD24, SDC1, and ST14 are strong molecular markers for such discrimination.
Source: Molecular and Cellular Toxicology - Category: Cytology Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Genetics | Pericarditis | PET Scan | Study | Toxicology